Clinical Trial Update: Sex Differences in NMDA-enhancing Treatment of Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on sex differences in an NMDA-enhancing treatment for schizophrenia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: China Medical University Hospital | Conditions: Schizophrenia | Phase 2 | Status: RECRUITING